Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
Register now or login to post to this thread.

Regenersis plc (RGS)     

dreamcatcher - 26 Sep 2012 20:57




We help our clients and their customers successfully deploy,
protect, maintain, retire and re-use technology.


The world is witnessing explosive growth in the number of connected devices, and in the power and complexity of mobile computing platforms. This is resulting in an increasing need for sophisticated technology- and user support. Regenersis addresses those needs with a growing portfolio of software-rich services building on a strong heritage of repair operations, customer service and data erasure management.

By combining our capabilities in innovative ways, tailored to individual client requirements, we deliver unique service propositions that reinforce trust in our client’s brands and create value for our business partners and shareholders.


Technology Life Cycle Services

Our international network of repair centres provides product repair, refurbishment, parts management and logistics services for mobile, IT, home entertainment and B2B infrastructure product vendors; and their sales channels, insurers, and end users. Our technically-advanced repair capabilities enjoy a solid reputation with our TMT sector clients, combining service excellence with continuous gains in cost efficiency.

Our industry-leading fault diagnostics and issue resolution technologies include the In-Field Tester for set top boxes, and our SmartChk applications suite for smartphones. These advanced diagnostic platforms improve consumer satisfaction with their devices and materially reduce the incidence and cost of product returns for our clients.

In partnership with leading insurers, our Digital Care operations deliver innovative product insurance and extended warranty programmes for our clients, protecting customers’ investments in mobile technology products.

Our Recommerce division helps manufacturers and retailers to launch products and attract new customers through upgrade and buy-back programmes.

Blancco is the global leader in data erasure management (DEM). Blancco software provides comprehensive data erasure for every type of electronic and magnetic storage media, ranging from portable flash drives and mobile phone memory to solid state drives, networked storage, virtual drives and cloud storage. Blancco DEM is a vital part of any organisation’s security infrastructure, underpinning robust data retention policies and ensuring compliance with international data protection regulations.

Regenersis around the world

Our clients increasingly seek partners who can deliver cost-effective and innovative technology life cycle services on a global basis. Since 2011, Regenersis has expanded its geographical footprint from five countries to 16. With the acquisition of Blancco in April 2014, this increased to 22 countries.



http://www.regenersis.com/about-us



Chart.aspx?Provider=EODIntra&Code=RGS&SiChart.aspx?Provider=EODIntra&Code=RGS&Si




Final Results

http://www.moneyam.com/action/news/showArticle?id=4451090

Financial Highlights

·
Group revenue increased by 13% to £139.9 million (2011: £123.8 million)

·
Headline operating profit(*) increased by 24% to £7.8 million (2011: £6.3 million)

·
Operating cash flow improved to £4.9 million (2011: £2.4 million).

·
Further Improvement in headline operating margin to 5.5% (2011: 5.1%)

·
Net debt reduced to £2.9 million (2011: £3.8 million)

·
Banking facility extended from £15 million to £23.25 million for the period to October 2015, to support further organic investment and incremental M&A activity

·
First dividend payment since 2007 - recommended final dividend of 1.1 pence per ordinary share

dreamcatcher - 14 Jan 2015 17:49 - 152 of 183

14 Jan Panmure Gordon 403.00 Buy

ExecLine - 15 Jan 2015 09:43 - 153 of 183

Director Deals - Regenersis PLC (RGS)

BFN

Dr Frank Blin, Non Executive Director, bought 18,000 shares in the company on the 14th January 2015 at a price of 248.50p. The Director now holds 18,000 shares.

Story provided by StockMarketWire.com
Director deals data provided by www.directorsholdings.com

dreamcatcher - 05 Feb 2015 19:39 - 154 of 183

The essential guide to aim stocks in Shares today -

Regenersis - Electronic data erasure and product recycler Regenersis has endured a tough 12 months. Its share price dropped 32% in 2014 after restructuring costs saw the business barely break even at the operating level.

dreamcatcher - 05 Mar 2015 18:28 - 155 of 183

Holding{s) company >5%

dreamcatcher - 12 Mar 2015 16:49 - 156 of 183

12 Mar Panmure Gordon 403.00 Buy

ExecLine - 17 Mar 2015 10:03 - 157 of 183

Why this stock deserves a rating of around £4.50 (.PDF)

Also, here's a 'Webinar invitation' for the discussion of today's H1 results by Matthew Peacock and Jog Dody, Executive Chairman and Jog Dhody, Chief Finance Officer:

https://attendee.gotowebinar.com/register/5356252567974984449

dreamcatcher - 22 Mar 2015 20:03 - 158 of 183

IC - Regenersis generates growth potential.

The depot solutions business gained £32m of new business during the first half, going some way to compensate for its now defunct UK mobile business. The shares are trading on 11 times this years earnings, which , considering the growth potential , looks like value.

ExecLine - 22 Mar 2015 22:34 - 159 of 183

Plus, roughly 50% of the profits from the business come from Euros and the other 50% from Polish Zlotys. These are both very weak at the moment but both are considered to be 'on the up'.

This would make 'now' an absolutely ideal time for an investment in RGS.

js8106455 - 24 Mar 2015 10:05 - 160 of 183

Regenersis - Interim Results Presentation

click here

Bullshare - 02 Apr 2015 16:38 - 161 of 183

Shares Investor Evenings showcase up to four presentations from leading companies bringing them together in one room for one evening only.

Directors present their latest plans regarding development and growthAn opportunity to talk directly to the companies and personally put forward your questionsThe chance to network with other attendees over drinks and canapés - private investors, wealth managers, private client brokers, fund managers and financial institutions
Who Should Attend?
The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.
Date:

Wednesday 29th April 2015

Venue:

Novotel Tower Bridge, London EC3N, 10 Pepys Street, London, EC3N 2NR

Event Timings:
18.00 
Registration and coffee
18.30 
Presentations
• John Cronin, Executive Chairman - Cyan Technology (CYAN)
• Crispin Simon, CEO - REX Bionics (RXB)
• Jog Dhody, CFO - Regenersis (RGS)
• Dr. Satu Vainikka, CEO - Valirx (VAL)
20.30 
Drinks reception and canapés
21.30 
Close
Attendance is free, but spaces are limited. Register now to secure your place!
Cyan Technology (CYAN)
Cyan Technology (CYAN) 

Cyan is an integrated system design company headquartered in Cambridge, with customers, staff and partners across many of the world’s largest emerging markets. It provides a communication platform that enables the measurement and control of energy consumption for smart metering and lighting. Cyan is focussed on emerging markets, where it’s low cost, low power solution provides significant customer benefits. It delivers integrated solutions to utilities, municipalities and local authorities, with customer wins to date in India, Brazil and China

Regenersis (RGS)
Regenersis (RGS) 

Regenersis is a leading, strategic outsourcing partner to the world’s premier consumer technology brands. Regenersis has built an increasingly global network of repair centres, delivered double digit revenue and profit growth, through cross-sell related services to major OEMs and network operators. In addition, the Group has traction with its scalable, high margin Advanced Solutions offering across the mobile and set top box markets.

REX Bionics (RXB)
REX Bionics (RXB) 

Rex Bionics Plc (The Rex Bionics Group) is the global technology leader in robotic walking devices (REX). Uniquely, REX® provides independent mobility to wheelchair users and other mobility impaired persons using advanced robotic technology, custom-designed electromechanical actuators, precision engineering, and specialised networking systems.

Today there are two primary REX devices available; an adjustable REX Rehab for use in rehabilitation centres, and a streamlined, fit-for-purpose REX Personal made for each individual’s specific medical and physical requirements enabling the user to perform tasks and functions previously unavailable.

Rex Bionics is a rapidly growing, exciting, innovative organisation which is proud to provide advanced robotics technology to people everywhere.

Valirx (VAL)
Valirx (VAL) 

Valirx Plc is an oncology-focussed Biopharmaceutical Company, developing treatments and diagnostics. Technologies are selected by using rigorous clinical and commercial processes to address unmet market needs.

Clinical lead product is VAL201, a peptide for prostate cancer with follow-on indications in ovarian and breast cancers and endometriosis. Product VAL401, is a small molecule reformulation for lung cancers.

The Company’s proprietary technology platform, GeneICE, enables selective silencing of rebellious genes’ inappropriate activity. VAL101, the first GeneICE therapeutic, targets and reduces expression of Bcl-2, implicated in about half of cancers. GeneICE extension to neurology and inflammatory diseases will follow.

A novel diagnostic, the Nav3 system, detects pre-cancerous, cancerous and metastatic cells in tissue samples even before a tumour forms; indicating potential malignant formation.

Sponsored by:
AJ Bell Youinvest
London Stock Exchange

cp1 - 13 Apr 2015 10:34 - 162 of 183

Somebody should ask the FD at the presentation why he runs a negatively geared balance sheet. This looks an attractive business but to me the FD is too inexperienced and clearly has annoyed a few in the city hence such a low rating. A share buyback / special dividend is what is required to restore some confidence. Until then it's a flat liner imo.

ExecLine - 13 Apr 2015 11:46 - 163 of 183

True. It does seem to be an excellent business and with good business prospects too. But the company needs much, much better financial management.

The FD needs a really good hammering at the 'Questions' section.


cp1 - 13 Apr 2015 12:56 - 164 of 183

It is plain dumb what they have done. I took a good profit when they raised the money for Blancco thinking I'd re-enter around 300p. That was over 12 months ago and at 210p I'm hardly chomping at the bit to start buying given the share price appears to be going no where. They raised too much cash which is now dragging eps down as it sits doing nothing. Either bolt on smaller rivals or return the cash. My only interest here is now via our share club and, whilst I think they have a great future, they certainly need to change things to get investors back excited.

Perhaps the arrival of Polygon and Reade Eugene Griffith on the share register this last couple of weeks will shake things up..

Otherwise wake me up once the FD has gone or changed his stance.

cp1 - 29 Apr 2015 08:41 - 165 of 183

Regenersis the share with great potential but imo a not very good FD running the show.

Just hope no one asks to pull up the 1 year chart at tonight's presentation. Any new investors should be warned of the permanent stock overhang as well.

I wish I could get to the presentation but business commitments.

ExecLine - 02 May 2015 12:03 - 166 of 183

Obviously, the FD didn't impress the people at the presentation.

Chart.aspx?Provider=EODIntra&Code=RGS&Si

cp1 - 07 May 2015 08:32 - 167 of 183

I don't think this will recover until the FD Dhody gets moved out. He's running this like a family business rather than looking after shareholders. Have you seen the remuneration packages and bonuses dished out last year? The institutions who stumped up 100 million euros at 345p must feel more than done over when they see how he's running things. As ever failure is rewarded once a company has PLC after its name.
The only hope here is if activist Polygon start building a stake and perhaps shake things up. AIM again!

ExecLine - 07 May 2015 12:36 - 168 of 183

Agreed about the FD. He is probably pretty good but someone needs have a word in his ear and maybe send him on a course or two to do with foreign currencies and hedging.

Pity really. It is a bloody good company.

One thing that might possibly happen, is that their software for cleaning disks gets put into operating system software. Now I can't really see that happening unless someone like Samsung takes them over. Or am I talking bollox?

cp1 - 08 May 2015 14:31 - 169 of 183

Taxi for Jog!! Will the city push him? The shareprice suggests so.

Share club meeting Saturday night. I doubt they'll be happy with me having suggested this to them near 350p. Ouch!! I'll keep my head down..

ExecLine - 08 May 2015 22:17 - 170 of 183

As the £GBP strengthens, Regenersis revenue and profits from the Polish Zloty and the Euro get worse.

(I think)

cp1 - 18 May 2015 16:00 - 171 of 183

Even the volume has dropped away here now. In all seriousness how is Dhody still running the finances here??

He's presented to investors (prospective) a few weeks ago (shares down 10% since) great work not.

Why hasn't he sanctioned a share buyback if the shares are such a good investment? It's a question that was asked at the interim presentation.

Why raise so much cash and not grow through acquisitions?

The shares are down a huge 40% from the placing over a year ago and nearly 50% from their peak.

and I thought Hanover were smart cookies!

Someone is accountable or is it a case of snouts in bonus trough???
Register now or login to post to this thread.